Kissei Pharmaceutical Co. Ltd. 13D and 13G filings for CG Oncology, Inc. Common stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-14 7:25 pm Purchase | 2024-01-29 | 13G | CG Oncology, Inc. Common stock CGON | Kissei Pharmaceutical Co. Ltd. | 3,543,533 5.300% | 3,543,533 (New Position) | Filing |